DK2891490T3 - Beta-3 adrenoceptor-agonister til behandlingen af pulmonal hypertension på grund af sygdom i venstre side af hjertet - Google Patents
Beta-3 adrenoceptor-agonister til behandlingen af pulmonal hypertension på grund af sygdom i venstre side af hjertet Download PDFInfo
- Publication number
- DK2891490T3 DK2891490T3 DK13785891.6T DK13785891T DK2891490T3 DK 2891490 T3 DK2891490 T3 DK 2891490T3 DK 13785891 T DK13785891 T DK 13785891T DK 2891490 T3 DK2891490 T3 DK 2891490T3
- Authority
- DK
- Denmark
- Prior art keywords
- beta
- treatment
- heart disease
- left heart
- adrenoceptor agonists
- Prior art date
Links
- 102100034159 Beta-3 adrenergic receptor Human genes 0.000 title 1
- 206010020772 Hypertension Diseases 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 108040005346 beta3-adrenergic receptor activity proteins Proteins 0.000 title 1
- 208000019622 heart disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201231343A ES2394349B1 (es) | 2012-08-29 | 2012-08-29 | Uso de agonistas selectivos de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar |
| PCT/ES2013/070611 WO2014033343A1 (es) | 2012-08-29 | 2013-08-28 | Agonistas de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2891490T3 true DK2891490T3 (da) | 2021-03-15 |
Family
ID=47520452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13785891.6T DK2891490T3 (da) | 2012-08-29 | 2013-08-28 | Beta-3 adrenoceptor-agonister til behandlingen af pulmonal hypertension på grund af sygdom i venstre side af hjertet |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10532038B2 (https=) |
| EP (1) | EP2891490B1 (https=) |
| JP (1) | JP6539206B2 (https=) |
| DK (1) | DK2891490T3 (https=) |
| ES (2) | ES2394349B1 (https=) |
| WO (1) | WO2014033343A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108290824B (zh) | 2015-10-23 | 2022-03-11 | B3Ar治疗股份有限公司 | 索拉贝隆两性离子及其应用 |
| WO2022198259A1 (en) * | 2021-03-25 | 2022-09-29 | The Heart Research Institute Ltd | Treatment methods for pulmonary arterial hypertension |
| US20240197660A1 (en) * | 2021-03-31 | 2024-06-20 | B3Ar Therapeutics, Inc. | Compositions of micronized solabegron and methods of use |
| IT202300021417A1 (it) | 2023-10-13 | 2025-04-13 | Univ Pisa | Agonisti o attivatori del recettore adrenergico beta-3 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0006735B1 (en) | 1978-06-28 | 1983-06-15 | Beecham Group Plc | Secondary amines, their preparation, pharmaceutical compositions containing them and their use |
| DE3061334D1 (en) | 1979-06-16 | 1983-01-20 | Beecham Group Plc | Ethanamine derivatives, their preparation and use in pharmaceutical compositions |
| DE3061205D1 (en) | 1979-06-16 | 1983-01-05 | Beecham Group Plc | Secondary amines, their preparation and use in pharmaceutical compositions |
| ES8800842A1 (es) | 1985-03-01 | 1987-12-01 | Beecham Group Plc | Un procedimiento para preparar una formulacion veterinariamente aceptable de ariletanolaminas promotora del crecimiento. |
| GB8528633D0 (en) | 1985-11-21 | 1985-12-24 | Beecham Group Plc | Compounds |
| IT1204416B (it) | 1986-06-27 | 1989-03-01 | Midy Spa | Medicamenti a base di analoghi di feniletanolammine per il trattamento di disturbi gastro-intestinali ed uterini |
| GB8801306D0 (en) | 1988-01-21 | 1988-02-17 | Ici Plc | Chemical compounds |
| DE69028877T2 (de) | 1989-06-13 | 1997-02-27 | Sanofi Sa | Verwendung von Phenylethanolaminen zur Herstellung von Medikamenten gegen Augenleiden |
| GB8925032D0 (en) | 1989-11-06 | 1989-12-28 | Ici Plc | Chemical compounds |
| US5061727A (en) | 1990-05-04 | 1991-10-29 | American Cyanamid Company | Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles |
| ATE185564T1 (de) | 1992-08-31 | 1999-10-15 | Sankyo Co | Oxazolidin-derivate mit antidiabetika und anti- fettleibigkeit-eigenschaften, ihre herstellung und therapeutische verwendung |
| US5578638A (en) | 1993-11-05 | 1996-11-26 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists |
| US5776983A (en) | 1993-12-21 | 1998-07-07 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
| IL113084A (en) | 1994-03-23 | 1999-01-26 | Sankyo Co | Thiazolidine and oxazolidine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same |
| IL113410A (en) | 1994-04-26 | 1999-11-30 | Merck & Co Inc | Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them |
| US5561142A (en) | 1994-04-26 | 1996-10-01 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
| US5705515A (en) | 1994-04-26 | 1998-01-06 | Merck & Co., Inc. | Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity |
| NZ295749A (en) | 1994-11-29 | 1998-05-27 | Dainippon Pharmaceutical Co | Indole derivatives; preparation and medicaments for treating obesity and diabetes mellitus |
| US5541204A (en) | 1994-12-02 | 1996-07-30 | Bristol-Myers Squibb Company | Aryloxypropanolamine β 3 adrenergic agonists |
| KR19990045727A (ko) | 1995-09-21 | 1999-06-25 | 피터 지. 스트링거 | 선택적 β３ 아드레날린 효능제 |
| ZA967892B (en) | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
| CZ126598A3 (cs) | 1995-10-26 | 1998-09-16 | Mitsubishi-Tokyo Pharmaceuticals, Inc. | Fenylethanolaminové sloučeniny, způsob jejich výroby a farmaceutické prostředky s jejich obsahem |
| CA2242351C (en) | 1996-01-10 | 2003-03-11 | Asahi Kasei Kogyo Kabushiki Kaisha | Novel tricyclic compounds and drug compositions containing the same |
| US5770615A (en) | 1996-04-04 | 1998-06-23 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
| EP0801060A1 (en) | 1996-04-09 | 1997-10-15 | Pfizer Inc. | Heterocyclic Beta-3 Adrenergenic Agonists |
| CA2257206A1 (en) | 1996-06-07 | 1997-12-11 | Gui-Bai Liang | Oxadiazole benzenesulfonamides as selective .beta.3 agonists for the treatment of diabetes and obesity |
| EP0827746B1 (en) | 1996-09-05 | 2002-04-03 | Eli Lilly And Company | Carbazole analogues as selective beta3 adrenergic agonists |
| KR20000070568A (ko) | 1997-01-28 | 2000-11-25 | 폴락 돈나 엘. | 당뇨병 및 비만 치료를 위한 β3 효능제로서의 티아졸 벤젠설폰아미드 |
| US6172099B1 (en) | 1997-07-03 | 2001-01-09 | Asahi Kasei Kogyo Kabushiki Kaisha | Tricyclic compounds having saturated rings and medicinal compositions containing the same |
| ES2398097T3 (es) | 2000-07-13 | 2013-03-13 | Eli Lilly And Company | Agonistas adrenérgicos beta3 |
| US6537994B2 (en) | 2000-07-17 | 2003-03-25 | Wyeth | Heterocyclic β3 adrenergic receptor agonists |
| US20040242485A1 (en) | 2003-05-30 | 2004-12-02 | Takashi Kadowaki | Compositions and methods for the amelioration of leptin resistance |
| US20130143797A1 (en) | 2010-06-25 | 2013-06-06 | Michael J. Tisdale | Glycoproteins Having Lipid Mobilizing Properties an Therapeutic Uses Thereof |
| CN102764438A (zh) * | 2012-01-30 | 2012-11-07 | 林曙光 | β3肾上腺素受体激动剂的新用途 |
-
2012
- 2012-08-29 ES ES201231343A patent/ES2394349B1/es not_active Withdrawn - After Issue
-
2013
- 2013-08-28 ES ES13785891T patent/ES2863749T3/es active Active
- 2013-08-28 JP JP2015529082A patent/JP6539206B2/ja not_active Expired - Fee Related
- 2013-08-28 DK DK13785891.6T patent/DK2891490T3/da active
- 2013-08-28 EP EP13785891.6A patent/EP2891490B1/en active Active
- 2013-08-28 US US14/424,861 patent/US10532038B2/en active Active
- 2013-08-28 WO PCT/ES2013/070611 patent/WO2014033343A1/es not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015526497A (ja) | 2015-09-10 |
| ES2863749T3 (es) | 2021-10-11 |
| US10532038B2 (en) | 2020-01-14 |
| EP2891490B1 (en) | 2020-12-09 |
| ES2394349A8 (es) | 2013-04-25 |
| WO2014033343A1 (es) | 2014-03-06 |
| WO2014033343A9 (es) | 2014-04-24 |
| EP2891490A1 (en) | 2015-07-08 |
| ES2394349B1 (es) | 2013-11-04 |
| JP6539206B2 (ja) | 2019-07-03 |
| US20150374655A1 (en) | 2015-12-31 |
| ES2394349A1 (es) | 2013-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2023027I2 (el) | Ενωσεις πυριμιδινοδιονης εναντι καρδιακων παθησεων | |
| LTC2785706I2 (lt) | Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui | |
| EP2673286A4 (en) | THERAPEUTIC COMPOUNDS | |
| BR112014001242A2 (pt) | bomba cardíaca | |
| EP2787837A4 (en) | COMMONLY DECOMPOSED STABILIZER COMPOSITION | |
| EP3636148C0 (en) | PORTABLE HEART MONITOR | |
| EP2863918A4 (en) | SALT CRYSTALS | |
| EP2890312A4 (en) | IMPLANT FOR CALCANUS EOSTEOTOMY | |
| CO7030959A2 (es) | Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a | |
| DK3489226T3 (da) | Hæmmere for natriumglucose-cotransporter 1 | |
| CR20130231A (es) | Compuestos antivirales | |
| BR112014007781A2 (pt) | compostos anti-virais | |
| EP2822935A4 (en) | INHIBITORS OF C-JUN-N-TERMINAL KINASE (JNK) | |
| DK2734106T3 (da) | Ekg-elektrodekonnektor | |
| BR112013023934A2 (pt) | bomba de tirar leite | |
| DK2838539T3 (da) | Østrogenderivater til anvendelse i behandlingen af neurologiske forstyrrelser | |
| EP2832740A4 (en) | SALT OF 1- (2-DEOXY-2-FLUORO-4-THIO-BETA-D-ARABINOFURANOSYL) CYTOSINE | |
| DK3360869T3 (da) | Halogen-substitueret heterocyklisk forbindelse anvendelig til behandlingen af sygdomme forårsaget af lpa. | |
| DK2627345T3 (da) | Formuleringer til behandling af sygdomme i de øvre luftveje | |
| EP2709619A4 (en) | COMPOUNDS FOR USE IN THE TREATMENT OF SACIAL SKIN INJECTION | |
| DK2888010T3 (da) | Fremgangsmåder til at hæmme fascin | |
| DK2903432T3 (da) | Fremgangsmåde til behandling af sædceller til kønsortering | |
| HUS2000037I1 (hu) | Triazinok Protozoa okozta betegségek kezelésére | |
| PL3520828T3 (pl) | Odkomórkowione matryce tkanek mięśniowych | |
| ES2627541T8 (es) | Métodos para tratar la enfermedad de Parkinson |